Chris Mirabelli
About Chris Mirabelli
Chris Mirabelli is the CEO of HealthCare Ventures LLC and has extensive experience in the biotechnology sector, having held leadership roles at Leap Therapeutics and Ionis Pharmaceuticals. He holds a Ph.D. in molecular pharmacology and serves on several boards, including the Scripps Research Board of Overseers and the Fredonia College Foundation.
Work at Leap Therapeutics
Chris Mirabelli served as President and CEO of Leap Therapeutics from 2011 until March 2020. During his tenure, he contributed to the strategic direction and operational management of the company. He has also held the position of Chairman of Leap’s board of directors since 2016, overseeing governance and guiding the organization’s mission.
Education and Expertise
Chris Mirabelli holds a Bachelor of Science in biology from the State University of New York at Fredonia and a Ph.D. in molecular pharmacology from Baylor College of Medicine. His educational background provides a strong foundation in biological sciences and pharmacology, which supports his leadership roles in the biotechnology and pharmaceutical sectors.
Background
Chris Mirabelli began his career at SmithKline and French Laboratories in the R&D Division. He has extensive experience in the pharmaceutical industry, having held several positions at Ionis Pharmaceuticals, including Senior Vice President of Research. He also served as President of Pharmaceutical Research and Development at Millennium Pharmaceuticals and was a co-founder of Ionis Pharmaceuticals.
Achievements
Chris Mirabelli has been a managing director of HealthCare Ventures LLC since 2000. He is a member of the Scripps Research Board of Overseers and serves on the Fredonia College Foundation Board of Directors. Additionally, he is part of the Dana-Farber Cancer Institute-Business Development Council and the Longview Ventures Investment Committee, reflecting his active involvement in advancing healthcare initiatives.